SR NIACIN VERSUS IHN: LIPID-ALTERING AND METABOLIC EFFECTS

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The intent of this double-blind randomized 6-week study is to compare to placebo SR niacin's and IHN's abilities to improve heart health, promote normal cholesterol levels and minimize side effects when coupled with a heart-healthy diet. Our goal is to learn more about the CVD-related effects of two common over-the-counter preparations to niacin.